Comments
Loading...

Viridian Therapeutics (VRDN) Stock Price, Quote, News & History

VRDNNASDAQ
Logo brought to you by Benzinga Data
$33.03
0.722.23%
At close: Dec 15, 4:00 PM EST
$33.03
N/A
After Hours: 4:58 PM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Trends and Forecast

4
1
Aug
1
Oct
3
Nov
2
Dec
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
$33.67
Close
$33.03
Volume / Avg.
2.46M / 1.40M
Day Range
$32.72 - $34.04
52 Wk Range
9.90 - 33.34
Market Cap
$3.15B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
70
Short Interest
9.98%
Days to Cover
5.03

About

Sector
Health Care
Industry
Biotechnology
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-00...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
VRDN
IDYA

FAQ

Q

How do I buy Viridian Therapeutics (VRDN) stock?

A

You can purchase shares of Viridian Therapeutics (NASDAQ:VRDN) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Viridian Therapeutics (VRDN) stock?

A

Viridian Therapeutics has a consensus price target of $39.94.

Q

What is the current price for Viridian Therapeutics (VRDN)?

A

The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $33.03 last updated December 15, 2025 at 4:58 PM EST.

Q

Does Viridian Therapeutics (VRDN) pay a dividend?

A

There are no upcoming dividends for Viridian Therapeutics.

Q

When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?

A

Viridian Therapeutics does not have any upcoming earnings scheduled.

Q

Is Viridian Therapeutics (VRDN) going to split?

A

There is no upcoming split for Viridian Therapeutics.

Q

What sector and industry does Viridian Therapeutics (VRDN) operate in?

A

Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.